Pancreatic Cancer Research

ResearcherUmeå UniversityActive in the last 2 years

Joshua Cumming

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-3661-7443; OpenAlex author ID A5014998661. Sources: OpenAlex.

Their work

Papers
3 (first author 2, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
7
Papers, trials and grants by year

2022: 1 paper · 2023: 1 paper · 2024: none · 2025: 1 paper

Papers 3

  1. Dissecting FAP+ Cell Diversity in Pancreatic Cancer Uncovers an Interferon-Response Subtype of Cancer-Associated Fibroblasts with Tumor-Restraining Properties. Co-author DOI 10.1158/0008-5472.can-23-3252↗
  2. Extracellular Galectin 4 Drives Immune Evasion and Promotes T-cell Apoptosis in Pancreatic Cancer. First author DOI 10.1158/2326-6066.cir-21-1088↗
  3. High throughput screen in a co-culture model to uncover therapeutic strategies to potentiate the cancer-inhibiting properties of the tumor-stroma in pancreatic… First author DOI 10.1101/2022.03.11.483991↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Daniel Öhlund · 3 shared papers, 2022–2025 · strength 0.58
  2. Parniyan Maneshi · 1 shared paper, 2025 · strength 0.26
  3. Tommy Lidström · 1 shared paper, 2023 · strength 0.17
  4. Oskar Franklin · 1 shared paper, 2023 · strength 0.17
  5. Ioannis S. Pateras · 1 shared paper, 2023 · strength 0.17
  6. Margarita Espona‐Fiedler · 1 shared paper, 2022 · strength 0.16
  7. James E. Mason · 1 shared paper, 2022 · strength 0.16

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.